So in the fog of the long weekend, I forgot yesterday's longread, but we'll be back in business the rest of this week. Today's article looks at the amount of money the pharmaceutical industry has invested in lobbying against measures that would restrict access to drugs that are commonly-used to make meth. At one level, I understand that they are running a business and want to ensure market access for consumers who want their product. At another level, though, these lobbying sums are enormous, and certainly the industry must understand that much of this demand comes from illicit use.
"Merchants of Meth: How Big Pharma Keeps the Cooks in Business" by Jonah Eagle
Published in Mother Jones, July/August 2013
Eric
No comments:
Post a Comment